New Jersey-based CDMO Catalent grew its revenues in the second quarter but saw a significant fall in net earnings, but still beat analysts forecasts. It has…

France-based IBA Molecular has picked up two manufacturing sites, including one in the U.S., as part of its $690 million deal to buy the nuclear medicines…

Sun Pharma is said to be shopping its Ohm Laboratories plants in New Jersey as part of a manufacturing consolidation.

With its $830 million deal to buy Dendreon, Chinese conglomerate Sanpower Group takes on the expensive process of manufacturing prostate cancer vaccine…

India’s Aurobindo Pharma, which has been building its presence around the world, has struck a new deal to buy a generics manufacturer and plant in Portugal…

Swiss CMO Lonza, which has been searching for a game-changing M&A deal, looks to have unearthed one in contractor Capsugel.

Sanofi recently that it will sell off its generic drug unit in Europe, a decision that will affect two manufacturing plants in the Czech Republic and Romania.

A surplus Eli Lilly plant in Puerto Rico has a new owner, which intends to invest more than $90 million in upgrades and hire 350 workers.

Investors knew that Pfizer’s $14 billion acquisition of Medivation and its prostate cancer drug Xtandi would immediately boost the pharma giant’s earnings, but…

M&A